Home | Nimotuzumab inoperable esophageal epithelial tumors, Phase IV
Published clinical_trials Nimotuzumab inoperable esophageal epithelial tumors, Phase IV has 2 revisions.
RevisionStatus
Saved 23/07/2020 - 5:59pm by CIM
current revision (published)
Saved 23/07/2020 - 5:43pm by CIM
archived
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.